Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v5-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2018-04-18 | 2017-05-04 |
Drug Identification Number | 00397466 | 00397466 |
Brand name | CYSTO-CONRAY II | CYSTO-CONRAY II |
Common or Proper name | Iothalamate Meglumine Injection USP 17.2% | Iothalamate Meglumine Injection USP 17.2% |
Company Name | LIEBEL-FLARSHEIM COMPANY LLC | LIEBEL-FLARSHEIM COMPANY LLC |
Ingredients | IOTHALAMATE MEGLUMINE | IOTHALAMATE MEGLUMINE |
Strength(s) | 172MG | 172MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | URETHRAL | URETHRAL |
Packaging size | 250 mL, 500 mL | 250 mL, 500 mL |
ATC code | V08AA | V08AA |
ATC description | X-RAY CONTRAST MEDIA, IODINATED | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
Anticipated start date | ||
Actual start date | 2017-05-03 | 2017-05-04 |
Estimated end date | 2018-08-20 | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149. | Methapharm Inc. is the Canadian distributor of Cysto-Conray II. Please contact 1-800-287-7686 ext. 3 to speak with a Customer Service Representative. |
Health Canada comments |